Esophageal SCC
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of XB002 in Subjects With Solid Tumors (JEWEL-101) (NCT04925284) | Exelixis | 2021-06-07 |
| Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies (NCT04000529) | Novartis Pharmaceuticals | 2019-07-30 |
Track Esophageal SCC automatically
Every clearance here is in the API, with alerts when new ones post.